Therefore, targeting E2s to inhibit neddylation modification blocks the protein neddylation pathway and deactivates CRLs, triggering the aggregation of tumor-suppressive CRL substrates, stopping the cell cycle and impeding tumor growth and metastasis (Kurz et al., 2008). The gene discussed is IL31RA; the disease is neoplasm.